PROSPECTS FOR THE USE OF MOLECULAR GENETIC MARKERS TO IMPROVE DIAGNOSTICS AND TARGETED THERAPY OF MELANOMA
Journal: Cardiometry
Year: 2022

Skin melanoma is a highly aggressive malignant neoplasm, the treatment of disseminated forms of which remains a serious problem, despite recent advances in the development of medical drugs based on the inhibition of the BRAF oncogene as well as on the basis of immune response regulators [1]. In addition, the question of identifying prognostic markers of metastasis and diagnostic markers of skin melanoma remains relevant. Despite advances in understanding the pathogenesis of melanoma and the deve